4,800
Views
33
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological and Psychiatric Disorders - Review

A clinician’s guide to ADHD treatment options

, &
Pages 657-666 | Received 31 May 2017, Accepted 10 Jul 2017, Published online: 01 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hicran Doğru & İbrahim Selçuk Esin. (2022) Counsellors’ position in the child–teacher-parent axis in attention-deficit/hyperactivity disorder and learning disorders. British Journal of Guidance & Counselling 50:5, pages 732-742.
Read now
M Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, Jennifer G Erensen, Kathleen Beusterien, Marc J Cataldo, Bernadette Hallissey & Gregory W Mattingly. (2021) Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient Preference and Adherence 15, pages 1061-1073.
Read now
Ann Childress, Bernice Ponce De Leon & Mark Owens. (2018) QuilliChew extended-release chewable tablets for the treatment of ADHD in patients ages 6 years old and above. Expert Opinion on Drug Delivery 15:12, pages 1263-1270.
Read now

Articles from other publishers (30)

Kaitlyn McKenna, Sithara Wanni Arachchige Dona, Lisa Gold, Angela Dew & Ha N. D. Le. (2023) Barriers and Enablers of Service Access and Utilization for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Systematic Review. Journal of Attention Disorders 28:3, pages 259-278.
Crossref
A. B. Palchik. (2023) Encephalopathy of Prematurity: Invisible Cause of Cognitive and Behavioral Disorders. Human Physiology 49:3, pages 316-322.
Crossref
Andrew J. Cutler, Katsumi SuzukiBrittney StarlingKanan BalakrishnanMarina KomaroffSuzanne MeevesMariacristina CastelliAnn Childress. (2023) d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial . Journal of Child and Adolescent Psychopharmacology 33:5, pages 176-182.
Crossref
А. B. Palchik. (2023) Encephalopathy of Prematurity: Invisible Cause of the Cognitive and Behavioural Disorders. Физиология человека 49:3, pages 126-133.
Crossref
Nazar Muhammad, Bhavani G Murugesan, Prakamya Singal, Angelica Antai & Lakshit Jain. (2023) Diagnostic Dilemma of Differentiating Attention-Deficit/Hyperactivity Disorder (ADHD) From Mood Disorders and Other Common Psychiatric Illnesses in Substance Use Patient Population. Cureus.
Crossref
Soroush Bakhshi, Mehdi Tehrani-Doost & Seyed Amir Hossein Batouli. (2023) Fronto-Cerebellar Neurometabolite Alterations After Methylphenidate in Children and Adolescents With ADHD: A Proton Magnetic Resonance Spectroscopy Study. Journal of Attention Disorders 27:4, pages 410-422.
Crossref
Mehmet Akif Akıncı, Necati Uzun & Cem Gökçen. (2022) The Effects of Exercise in the Treatment of Attention Deficit Hyperactivity Disorder. Turkish Journal of Child and Adolescent Mental Health 29:3, pages 130-136.
Crossref
Amy Pipe, Nisha Ravindran, Angela Paric, Beth Patterson, Michael Van Ameringen & Arun V. Ravindran. (2022) Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review. Asian Journal of Psychiatry 76, pages 103232.
Crossref
Michael A. FederDouglas M. BrodmanZi Chun YangVanessa Y. T. NgSamantha GlickmanJacqueline SmithArgelinda BaroniErica WillheimTimothy L. Verduin. (2022) I'm Coming Home: Providing Parent Training to Support Inpatient Discharge Programs. The ADHD Report 30:5, pages 1-7.
Crossref
Cynthia P. Paidipati, Janet A. Deatrick, Ricardo B. Eiraldi, Connie M. Ulrich, Jamil M. Lane & Bridgette M. Brawner. (2021) Caregivers' perspectives on the contextual influences within family management for ethnically diverse children with ADHD. Journal for Specialists in Pediatric Nursing 27:2.
Crossref
Andrew J. Cutler, Katsumi SuzukiBrittney StarlingKanan BalakrishnanMarina KomaroffMariacristina CastelliSuzanne MeevesAnn C. Childress. (2022) Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study. Journal of Child and Adolescent Psychopharmacology 32:2, pages 89-97.
Crossref
Tanu Gupta & Kartik Singhai. 2022. Handbook of Research on Clinical Applications of Meditation and Mindfulness-Based Interventions in Mental Health. Handbook of Research on Clinical Applications of Meditation and Mindfulness-Based Interventions in Mental Health 144 152 .
Elena Eggert, Annet Bluschke, Adam Takacs, Maximilian Kleimaker, Alexander Münchau, Veit Roessner, Moritz Mückschel & Christian Beste. (2021) Perception-Action Integration Is Modulated by the Catecholaminergic System Depending on Learning Experience. International Journal of Neuropsychopharmacology 24:7, pages 592-600.
Crossref
Annet Bluschke, Nicolas Zink, Moritz Mückschel, Veit Roessner & Christian Beste. (2020) A novel approach to intra-individual performance variability in ADHD. European Child & Adolescent Psychiatry 30:5, pages 733-745.
Crossref
Gregory W. Mattingly & Joel Young. (2021) A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications. CNS Spectrums 26:2, pages 104-114.
Crossref
Mingming Zhou, Jodi Gresack, Jia Cheng, Kunihiro Uryu, Lars Brichta, Paul Greengard & Marc Flajolet. (2018) CK1δ over-expressing mice display ADHD-like behaviors, frontostriatal neuronal abnormalities and altered expressions of ADHD-candidate genes. Molecular Psychiatry 25:12, pages 3322-3336.
Crossref
Martin A. Katzman, Greg Mattingly, Larry J. Klassen, Marc J. Cataldo & Graeme A. E. Donnelly. (2020) Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults. Journal of Clinical Psychopharmacology 40:6, pages 579-587.
Crossref
Bobbi Fleiss, Pierre Gressens & Helen B. Stolp. (2020) Cortical Gray Matter Injury in Encephalopathy of Prematurity: Link to Neurodevelopmental Disorders. Frontiers in Neurology 11.
Crossref
Vincent E. Horne, Kevin Bielamowicz, Jessica Nguyen, Susan Hilsenbeck, Holly Lindsay, Rona Sonabend, Alexis C. Wood, Fatih Okcu & Stephanie Sisley. (2020) Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity. Pediatric Blood & Cancer 67:7.
Crossref
Moritz Mückschel, Veit Roessner & Christian Beste. (2020) Task experience eliminates catecholaminergic effects on inhibitory control – A randomized, double-blind cross-over neurophysiological study. European Neuropsychopharmacology 35, pages 89-99.
Crossref
Gideon Koren, Yael Barer & Asher Ornoy. (2020) Fetal safety of methylphenidate—A scoping review and meta analysis. Reproductive Toxicology 93, pages 230-234.
Crossref
Maik Pertermann, Annet Bluschke, Veit Roessner & Christian Beste. (2019) The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4:8, pages 743-750.
Crossref
Wiebke Bensmann, Nicolas Zink, Veit Roessner, Ann-Kathrin Stock & Christian Beste. (2019) Catecholaminergic effects on inhibitory control depend on the interplay of prior task experience and working memory demands. Journal of Psychopharmacology 33:6, pages 678-687.
Crossref
Sara SoufsafPhilippe RobaeyGuillaume BonnefoisFahima NekkaJun Li. (2019) A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder Treatment. Journal of Child and Adolescent Psychopharmacology 29:3, pages 220-234.
Crossref
Rachel L. Navarra & Barry D. Waterhouse. (2019) Considering noradrenergically mediated facilitation of sensory signal processing as a component of psychostimulant-induced performance enhancement. Brain Research 1709, pages 67-80.
Crossref
Gonzalo Salazar de Pablo, Julio David Vaquerizo Serrano, Sandra Gómez Vallejo, Javier Sánchez Cerezo & Carmen Moreno Ruiz. 2019. Frontiers in Psychiatry. Frontiers in Psychiatry 429 451 .
Nathan S. Teuscher, Carolyn R. SikesRuss McMahenDorothy Engelking. (2018) Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 38:5, pages 467-474.
Crossref
Katherine A. Lyseng-Williamson. (2018) Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use. Drugs & Therapy Perspectives 34:9, pages 411-419.
Crossref
Katherine A. Lyseng-Williamson. (2017) Methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT™) in attention-deficit hyperactivity disorder in children aged 6–17 years: a profile of their use. Drugs & Therapy Perspectives 34:2, pages 43-49.
Crossref
Annet Bluschke, Julia Friedrich, Marie Luise Schreiter, Veit Roessner & Christian Beste. (2018) A comparative study on the neurophysiological mechanisms underlying effects of methylphenidate and neurofeedback on inhibitory control in attention deficit hyperactivity disorder. NeuroImage: Clinical 20, pages 1191-1203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.